Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
Public ClinicalTrials.gov record NCT01766401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Flexible-Dose Study of Vilazadone in Patients With Generalized Anxiety Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD).
Study identification
- NCT ID
- NCT01766401
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 402 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2013 (Actual)
- Primary completion
- Jan 29, 2014 (Actual)
- Completion
- Jan 29, 2014 (Actual)
- Last update posted
- Dec 18, 2019
2013 – 2014
United States locations
- U.S. sites
- 30
- U.S. states
- 14
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 022 | Arcadia | California | 91007 | — |
| Forest Investigative Site 023 | Beverly Hills | California | 90210 | — |
| Forest Investigative Site 010 | Encino | California | 91316 | — |
| Forest Investigative Site 025 | Newport Beach | California | 92660 | — |
| Forest Investigative Site 004 | Redlands | California | 92374 | — |
| Forest Investigative Site 007 | Sherman Oaks | California | 91403 | — |
| Forest Investigative Site 016 | Temecula | California | 92562 | — |
| Forest Investigative Site 012 | Upland | California | 91786 | — |
| Forest Investigative Site 017 | Coral Springs | Florida | 33067 | — |
| Forest Investigative Site 028 | Fort Myers | Florida | 33912 | — |
| Forest Investigative Site 002 | Jacksonville | Florida | 32256 | — |
| Forest Investigative Site 020 | Leesburg | Florida | 34748 | — |
| Forest Investigative Site 024 | Miami | Florida | 33015 | — |
| Forest Investigative Site 001 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 026 | Indianapolis | Indiana | 46260 | — |
| Forest Investigative Site 029 | Shreveport | Louisiana | 71104 | — |
| Forest Investigative Site 019 | Las Vegas | Nevada | 89102 | — |
| Forest Investigative Site 003 | Canton | Ohio | 44718 | — |
| Forest Investigative Site 031 | Columbus | Ohio | 43210 | — |
| Forest Investigative Site 021 | Mason | Ohio | 45040 | — |
| Forest Investigative Site 030 | Oklahoma City | Oklahoma | 73112 | — |
| Forest Investigative Site 005 | Salem | Oregon | 97301 | — |
| Forest Investigative Site 014 | Allentown | Pennsylvania | 18104 | — |
| Forest Investigative Site 015 | Philadelphia | Pennsylvania | 19139 | — |
| Forest Investigative Site 027 | Lincoln | Rhode Island | 02865 | — |
| Forest Investigative Site 006 | Memphis | Tennessee | 38119 | — |
| Forest Investigative Site 008 | Houston | Texas | 77054 | — |
| Forest Investigative Site 018 | Houston | Texas | 77096 | — |
| Forest Investigative Site 011 | Murray | Utah | 84123 | — |
| Forest Investigative Site 013 | Woodstock | Vermont | 05091 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01766401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2019 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01766401 live on ClinicalTrials.gov.